Exegenesis Bio
Philadelphia, Pennsylvania, United States · Biotechnology, Genetics, Health Care
Exegenesis Bio is a clinical stage global gene therapy company focused on developing innovative treatments for rare diseases. Their flagship product, EXG110, aims to treat Fabry disease through a novel gene therapy approach. The company emphasizes its commitment to rigorous science and innovation in the field of gene therapy. Exegenesis Bio is also working on additional therapies targeting other c
Key facts
- Headquarters
- Philadelphia, Pennsylvania, United States
- Employees
- 18
- Industries
- Biotechnology, Genetics, Health Care
- Status
- Private
- Website
- exegenesisbio.com
- Company page
Recent activity at Exegenesis Bio
Leadership
- 晓燕 汪, Senior Financial Director
- Alisha Bouge, Ms, Rac
- Zhenhua Wu, Founder, President and CEO
- Cj Song, Scientist and Team Leader
- Guo-Jie Ye, Aav Vector Development for Gene Therapy
- Mahen Gundecha, Biotechnology Leader With Significant Experience
Verified email and direct lines for Exegenesis Bio’s decision-makers are on Fundz. See plans
Employee benefit plans
Exegenesis Bio files 1 employee benefit plan with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Exegenesis Bio in the news
Companies similar to Exegenesis Bio
- Junevity · Biotechnology, Genetics, Health Care, Therapeutics
- Aurora Therapeutics · Biotechnology, Genetics, Health Care, Therapeutics
- Aptadir Therapeutics · Biotechnology, Genetics, Health Care, Therapeutics
- MeiraGTx Holdings plc · Biotechnology, Genetics, Health Care, Therapeutics
- Gaomei Gene · Biotechnology, Genetics, Health Care, Therapeutics
About Exegenesis Bio: questions and answers
What does Exegenesis Bio do?
Exegenesis Bio is a clinical stage global gene therapy company focused on developing innovative treatments for rare diseases. Their flagship product, EXG110, aims to treat Fabry disease through a novel gene therapy approach. The company emphasizes its commitment to rigorous science and innovation in the field of gene therapy. Exegenesis Bio is also working on additional therapies targeting other c
Where is Exegenesis Bio headquartered?
Exegenesis Bio is headquartered in Philadelphia, Pennsylvania, United States.
How many employees does Exegenesis Bio have?
Exegenesis Bio has about 18 employees.
Who leads Exegenesis Bio?
Zhenhua Wu is a Founder, President and CEO at Exegenesis Bio.
What is the latest news on Exegenesis Bio?
On Sep 11, 2026, Exegenesis Bio and Modalis Enter Partnership to Develop MDL-201 for Duchenne Muscular Dystrophy.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy